Literature DB >> 19019563

Semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging measurements predict radiation response in cervix cancer.

Mark A Zahra1, Li Tee Tan, Andrew N Priest, Martin J Graves, Mark Arends, Robin A F Crawford, James D Brenton, David J Lomas, Evis Sala.   

Abstract

PURPOSE: To evaluate semiquantitative and quantitative dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI) measurements in predicting the response to radiotherapy in cervix cancer. METHODS AND MATERIALS: Patients with cervix cancer treated radically with chemoradiotherapy had DCE-MRI at three time points: before starting treatment, after 2 weeks of radiotherapy, and in the 5th week of radiotherapy. Semiquantitative measurements obtained from the signal intensity vs. time plots included arrival time of contrast, the slope and maximum slope of contrast uptake, time for peak enhancement, and the contrast enhancement ratio (CER). Pharmacokinetic modeling with a modeled vascular input function was used for the quantitative measurements volume transfer constant (K(trans)), rate constant (k(ep)), fraction plasma volume (fPV), and the initial area under gadolinium-time curve. The correlation of these measurements at each of the three time points with radiologic tumor response was investigated.
RESULTS: Thirteen patients had a total of 38 scans. There was no correlation between the DCE-MRI measurements and the corresponding tumor volumes. A statistically significant correlation with percentage tumor regression was shown with the pretreatment DCE-MRI semiquantitative parameters of peak time (p = 0.046), slope (p = 0.025), maximum slope (p = 0.046), and CER (p = 0.025) and the quantitative parameters K(trans) (p = 0.043) and k(ep) (p = 0.022). Second and third scan measurements did not show any correlation.
CONCLUSIONS: This is the first study to show that pretreatment DCE-MRI quantitative parameters predict the radiation response in cervix cancer. These measurements may allow a more meaningful comparison of DCE-MRI studies from different centers.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19019563     DOI: 10.1016/j.ijrobp.2008.08.023

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  52 in total

1.  Multi-parametric MRI in cervical cancer: early prediction of response to concurrent chemoradiotherapy in combination with clinical prognostic factors.

Authors:  Wei Yang; Jin Wei Qiang; Hai Ping Tian; Bing Chen; Ai Jun Wang; Jian Guo Zhao
Journal:  Eur Radiol       Date:  2017-08-04       Impact factor: 5.315

Review 2.  Diffusion-weighted (DW) and dynamic contrast-enhanced (DCE) magnetic resonance imaging (MRI) for monitoring anticancer therapy.

Authors:  Anwar R Padhani; Aftab Alam Khan
Journal:  Target Oncol       Date:  2010-04-11       Impact factor: 4.493

Review 3.  Applications of molecular imaging.

Authors:  Craig J Galbán; Stefanie Galbán; Marcian E Van Dort; Gary D Luker; Mahaveer S Bhojani; Alnawaz Rehemtulla; Brian D Ross
Journal:  Prog Mol Biol Transl Sci       Date:  2010       Impact factor: 3.622

Review 4.  Tracer kinetic modelling of tumour angiogenesis based on dynamic contrast-enhanced CT and MRI measurements.

Authors:  Gunnar Brix; Jürgen Griebel; Fabian Kiessling; Frederik Wenz
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-08       Impact factor: 9.236

5.  Dynamic contrast-enhanced MRI, diffusion-weighted MRI and 18F-FDG PET/CT for the prediction of survival in oropharyngeal or hypopharyngeal squamous cell carcinoma treated with chemoradiation.

Authors:  Shu-Hang Ng; Chun-Ta Liao; Chien-Yu Lin; Sheng-Chieh Chan; Yu-Chun Lin; Tzu-Chen Yen; Joseph Tung-Chieh Chang; Sheung-Fat Ko; Kang-Hsing Fan; Hung-Ming Wang; Lan-Yan Yang; Jiun-Jie Wang
Journal:  Eur Radiol       Date:  2016-02-24       Impact factor: 5.315

6.  Dynamic contrast-enhanced MR microscopy identifies regions of therapeutic response in a preclinical model of colorectal adenocarcinoma.

Authors:  Ergys Subashi; Yi Qi; G Allan Johnson
Journal:  Med Phys       Date:  2015-05       Impact factor: 4.071

Review 7.  Biological imaging in clinical oncology: radiation therapy based on functional imaging.

Authors:  Yo-Liang Lai; Chun-Yi Wu; K S Clifford Chao
Journal:  Int J Clin Oncol       Date:  2016-07-06       Impact factor: 3.402

Review 8.  Magnetic resonance imaging in precision radiation therapy for lung cancer.

Authors:  Hannah Bainbridge; Ahmed Salem; Rob H N Tijssen; Michael Dubec; Andreas Wetscherek; Corinne Van Es; Jose Belderbos; Corinne Faivre-Finn; Fiona McDonald
Journal:  Transl Lung Cancer Res       Date:  2017-12

9.  Pretreatment diffusion-weighted and dynamic contrast-enhanced MRI for prediction of local treatment response in squamous cell carcinomas of the head and neck.

Authors:  Sanjeev Chawla; Sungheon Kim; Lawrence Dougherty; Sumei Wang; Laurie A Loevner; Harry Quon; Harish Poptani
Journal:  AJR Am J Roentgenol       Date:  2013-01       Impact factor: 3.959

10.  Enhancing fraction measured using dynamic contrast-enhanced MRI predicts disease-free survival in patients with carcinoma of the cervix.

Authors:  S B Donaldson; D L Buckley; J P O'Connor; S E Davidson; B M Carrington; A P Jones; C M L West
Journal:  Br J Cancer       Date:  2009-11-17       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.